During the past decade, Karolina Korhaz Rendelointezet conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 12 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karolina Korhaz Rendelointezet" #1 sponsor was "Pfizer" with 4 trials, followed by "Takeda" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Artu Biologicals" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karolina Korhaz Rendelointezet" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Athersys, Inc" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Karolina Korhaz Rendelointezet" are "Ulcerative Colitis" (10 trials), "Crohn's Disease" (5 trials), "Colitis, Ulcerative" (4 trials), "Allergic Rhinoconjunctivitis" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Karolina Korhaz Rendelointezet" in a lesser frequency.

Most popular intervention types in "Karolina Korhaz Rendelointezet" are "Drug" (22 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Filgotinib" (4 trials), "CP-690,550" (2 trials), "Mesalamine" (2 trials) and "Oralgen" (2 trials). Other intervention names were less common.

The vast majority of trials in "Karolina Korhaz Rendelointezet" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Karolina Korhaz Rendelointezet". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Karolina Korhaz Rendelointezet, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Karolina Korhaz Rendelointezet, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".